What Waters's latest 10-Q says: 7 signals
Waters filed its latest 10-Q with the SEC on Aug 11, 2026. It discusses acquisition completed, capex increase and legacy modernization.
Public (WAT)Biotechnology Research10,000+ employeeswaters.comLinkedIn
- Filed
- Aug 11, 2026
- Filings
- 2
- Signals
- 16
10-Q · latest 10
What Waters's 10-Q filings say
- SEC EDGAR
10-Q
Filed · 7 signals
Following the BDS Business acquisition, Waters is paying BD $90M/year for up to three years for critical back-office functions including IT, finance, and HR.
$90M
annual cost of Transition Services Agreement (TSA)
Integrating BDS Business acquisition with $90M annual transition services agreement.
This creates significant budget pressure and a clear timeline to replace these temporary services with permanent, cost-effective systems and solutions.
$90M
Annual cost for Transition Services Agreement (TSA) with BD for back-office, IT, finance, and HR support following the BDS Business Acquisition.
BD
Company undergoing transition to a new ERP system, citing operational disruption risks.
Waters explicitly states it is transitioning to a new ERP system, a major IT and operational overhaul.
ERP
Facing increased competitive and regulatory pressures in the Chinese market.
Waters is experiencing significant challenges in China, including trade tensions, increased local competition, and government procurement restrictions.
- SEC EDGAR
10-Q
Filed · 9 signals
The company has completed its acquisition of the BDS Business (SpinCo) from Becton, Dickinson and Company, and is now focused on integration.
Becton, Dickinson and Company
Integrating BDS Business Acquisition, facing risks of delayed synergies and integration challenges.
Waters is integrating the newly acquired BDS business from Becton, Dickinson and Company as of February 2026.
Becton, Dickinson and CompanyBarclay Bank PLCU.S. Bank Trust Company, National Association
Company undergoing a new ERP system transition, acknowledging potential for operational disruptions.
Waters is in the process of transitioning to a new ERP system.
ERP
Waters Corp faces integration challenges following BDS Business Acquisition
The company flags potential delays and failure to achieve synergies from the recent BDS Business Acquisition as a key risk.
Becton, Dickinson and CompanyBarclays Bank PLCU.S. Bank Trust Company, National Association
Waters Corp is undergoing a transition to a new ERP system, flagging risk of disruption.
The company is in the process of a major IT overhaul by implementing a new ERP system.
ERP
Facing cybersecurity threats from state-sponsored actors targeting proprietary data.
Waters explicitly calls out the risk of attacks from 'private and state-sponsored' third parties attempting to access sensitive company data, products, and systems.
Showing 10 of 16 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Waters earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Raised full-year revenue and earnings guidance, signaling strong financial health.The company increased its full-year 2025 sales growth forecast to a 7% midpoint and expects double-digit EPS growth. This strong financial performance and positive outlook indicate available budget and confidence in making new investments. | |
| Actively planning integration for major acquisition of BD's Biosciences business.Waters is deep in integration planning for its combination with BD's Biosciences & Diagnostic Solutions business, closing in Q1 2026. This massive effort involves mobilizing 120+ leaders and multiple workstreams, creating significant opportunities for consulting, systems integration, and operational efficiency vendors. | |
| Modernizing Empower platform with AI/ML and shifting to subscription modelA significant release cadence is planned for 2026 to evolve the core Empower software into a modern, cloud-native platform using AI/ML. The company is actively transitioning large pharma customers from perpetual licenses to a subscription model, signaling budget for cloud, AI, and customer success technologies. | |
| New FDA guidance on biosimilars expected to increase demand for analytical testingThe FDA is proposing to reduce reliance on clinical studies for biosimilar approvals in favor of advanced analytical characterization. This regulatory shift creates a significant tailwind and budget driver for analytical instruments and compliant software workflows within their pharma customer base. | |
| Investing in AI/ML and cloud to modernize flagship Empower software platform.Waters is evolving its core Empower informatics platform into a modern, cloud-native system using AI and machine learning. This strategic initiative aims to reduce manual work, minimize compliance risks, and enhance instrument uptime, signaling significant investment in data, AI, and cloud technologies. | |
| Acknowledges customer pain from compliance risks due to human errorLeadership explicitly identified minimizing compliance risks from human error as a key value driver for its customers in QA/QC labs. This highlights a critical pain point that solutions focused on automation, data integrity, and error reduction can address. |
Signal API · MCP
Track Waters with the Signal API
One POST /v1/companies/enrich call with waters.com returns Waters 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"waters.com","signal_types":["sec-10q"],"limit":20}'Same industry
10-Q at related companies
Questions about Waters 10-Q
When did Waters file its latest 10-Q?
What did Waters disclose in its latest 10-Q?
What did Waters say on its recent earnings calls?
Where can I read Waters's 10-Q filing?
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .